Sinopharm
1099.HK
#2481
Rank
โ‚น703.21 B
Marketcap
โ‚น225.34
Share price
-0.85%
Change (1 day)
18.92%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น217.99 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น217.99 Billion a decrease over its 2023 earnings that were of โ‚น302.18 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น217.99 B-27.86%
2023โ‚น302.18 B-0.73%
2022โ‚น304.40 B-1.72%
2021โ‚น309.72 B11.7%
2020โ‚น277.27 B18.44%
2019โ‚น234.10 B10.85%
2018โ‚น211.19 B3.05%
2017โ‚น204.94 B36.48%
2016โ‚น150.16 B7.11%
2015โ‚น140.19 B12.38%
2014โ‚น124.75 B25.05%
2013โ‚น99.76 B22.54%
2012โ‚น81.41 B35.43%
2011โ‚น60.11 B52.24%
2010โ‚น39.48 B30.99%
2009โ‚น30.14 B60.59%
2008โ‚น18.77 B48.29%
2007โ‚น12.65 B123.29%
2006โ‚น5.66 B